Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

This genetic association study evaluates the association of protein-truncating variants in APOB and PCSK9 with low-density lipoprotein (LDL) cholesterol levels and coronary heart...

The lipid-lowering landscape is rapidly evolving and several trials published this year provided new insights. The CORDIOPREV Trial was a Spanish single...

A desire for better work conditions and real-world impact are behind the movement, which may hinder academic clinical trials while leading to beneficial...

An unexpected alliance is lobbying for Medicare to pay for new obesity...

  • 1618638712799203328 Profile photo of Madelyn

    Did not realize this: “Medicare is prohibited by law from paying…Lawmakers banned coverage of obesity drugs when program’s prescription drug benefit was created in 2003,…” Needs to change as obesity is THE driver for most diseases today (CVD, cancer) https://t.co/MLiWXELnZx - view on twitter

Companies at the frontiers of science and medicine, developing new therapies for patients, are working on one of the most challenging endeavors known to...

Buoyed by recent approvals, the field faces a pivotal year that’s likely to bring new treatments as well as more...